Tuberculosis susceptibility and protection in children
Robindra Basu Roy1, Elizabeth Whittaker2, James A Seddon2
1Centre for International Child Health, Department of Paediatrics, Imperial College London, London, UK; Vaccines and Immunity Theme MRC Unit The Gambia at London School of Hygiene and Tropical Medicine, Fajara, The Gambia.
Insights
Children under 5 are highly susceptible to tuberculosis (TB) disease. Identifying biomarkers like monocyte-to-lymphocyte ratio can help develop new TB vaccines for children.
Area of Science:
- Pediatric infectious diseases
- Immunology
- Vaccinology
Background:
- Children under 5 are highly susceptible to tuberculosis (TB) infection, disease, and mortality.
- Risk of TB increases again in adolescence, with a protective effect observed in children aged 5-10 years.
- Neonatal Bacillus Calmette-Guérin (BCG) vaccination offers the clearest proven benefit against TB.
Purpose of the Study:
- To identify host immune correlates of risk for developing tuberculosis in children.
- To guide the development of novel tuberculosis vaccines for pediatric populations.
- To contribute to the World Health Organization's goal of eliminating childhood TB deaths.
Main Methods:
- Analysis of large case-control cohorts comprising over 15,000 children and adolescents.
- Investigation of potential biomarkers including monocyte-to-lymphocyte ratio, CD4 T cell counts, and blood RNA signatures.
Main Results:
- Identified the monocyte-to-lymphocyte ratio, activated CD4 T cell count, and a blood RNA signature as potential correlates of risk for TB development.
- Highlighted distinct susceptibility patterns across different pediatric age groups.
Conclusions:
- Specific immune and molecular signatures correlate with tuberculosis risk in children.
- Further research into these correlates is crucial for developing effective pediatric TB vaccines.
- Understanding age-specific susceptibility is key to achieving global TB elimination goals in children.
Abstract:
Children represent both a clinically important population susceptible to tuberculosis and a key group in whom to study intrinsic and vaccine-induced mechanisms of protection. After exposure to Mycobacterium tuberculosis, children aged under 5 years are at high risk of progressing first to tuberculosis infection, then to tuberculosis disease and possibly disseminated forms of tuberculosis, with accompanying high risks of morbidity and mortality. Children aged 5-10 years are somewhat protected, until risk increases again in adolescence. Furthermore, neonatal BCG programmes show the clearest proven benefit of vaccination against tuberculosis. Case-control comparisons from key cohorts, which recruited more than 15 000 children and adolescents in total, have identified that the ratio of monocytes to lymphocytes, activated CD4 T cell count, and a blood RNA signature could be correlates of risk for developing tuberculosis. Further studies of protected and susceptible populations are necessary to guide development of novel tuberculosis vaccines that could facilitate the achievement of WHO's goal to eliminate deaths from tuberculosis in childhood.
Related Concept Videos
Magnetic Susceptibility and Permeability
When diamagnetic materials are placed under an external magnetic field, the moments opposite to the field are induced. Hence, the susceptibility for diamagnets has a minimal negative value of 10-5–10-6. Since...
Protection of Alcohols
Protection
It defines a protecting group as the masking agent to make the more reactive species inert to a given set of conditions. This concept is depicted via the illustration of liquid flow through different outlets in an assembly of pipes. The analogy helps to understand the role...
Zones of Protection
Protective zones are defined by closed dashed lines, containing one or more components. A key characteristic of these zones is the strategic placement of...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...


